Analysis into biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin antibiotics at frequent doses added to bone cement
Aims: This research goals to research the biocompatibility and cytotoxicity of daptomycin, gentamicin, vancomycin and teicoplanin at commonly-used dose intervals added to polymethylmethacrylate (PMMA) in vitro.
Supplies and strategies: This potential research was carried out between February 2016 and June 2016. Antibiotics have been added to PMMA at doses continuously utilized in scientific observe. The antibiotic doses added have been teicoplanin (2 g, three g, four g), gentamicin (0.5 g, 0.75 g, 1 g), daptomycin (0.5 g.) and vancomycin (2 g, three g, four g).
Normal cement balls (10 mm) have been created. Activated L929 mouse fibroblast cell tradition was used for incubation. Agar diffusion, Cell Proliferation Equipment II (XTT) check and electron microscope investigations have been carried out to look at biocompatibility and cytotoxicity.
Outcomes: Within the cytotoxicity check, teicoplanin at four g and daptomycin at 0.5 g doses have been noticed to trigger reductions in viability percentages. The identical doses induced 20% and 20-40% cell lysis indices throughout the agar diffusion check. On electron microscope photographs, cytotoxic results in fibroblast cells and involvement with the floor of cement balls have been noticed.
Conclusion: Gentamicin, vancomycin and teicoplanin have been noticed to be non-toxic and biocompatible at commonly-used dose intervals. Teicoplanin at four g and daptomycin at 0.5 g doses have been recognized to be cytotoxic and never biocompatible. When deciding on antibiotics to be added to bone cement, care ought to be taken that the antibiotic is non-toxic and biocompatible.
An in vivo and in vitro comparability of the consequences of amoxicillin, gentamicin, and cefazolin sodium antibiotics on the mouse hepatic and renal glutathione reductase enzyme.
Although using antibiotics is rising worldwide, it’s clear that antibiotics can result in oxidative stress. That is the primary research to make a comparability of the influence of continuously prescribed antibiotics, together with amoxicillin, gentamicin, and cefazolin sodium, on the gene, protein, and exercise of glutathione reductase (GR), which is likely one of the major antioxidant enzymes, in mouse liver and kidney tissues.
- First, the GR enzyme was purified by the 2′,5′-ADP Sepharose 4B affinity chromatography with a particular exercise of 84.615 EU/mg protein and 9.63 EU/mg protein from the mouse liver and kidney, respectively. The in vitro inhibitory results of the antibiotics in query was decided.
- Whereas cefazolin sodium didn’t exhibit any inhibitory impact, gentamicin and amoxicillin inhibited GR exercise in each tissues.
- Moreover, the in vivo results of those medicine have been investigated, and amoxicillin and cefazolin sodium-inhibited GR exercise in each liver and kidney tissues, whereas gentamicin didn’t have any impact on the kidney. Apart from, whereas gentamicin downregulated and cefazolin sodium upregulated Gr gene expression, amoxicillin didn’t alter it.
- Protein expression was solely affected by the administration of cefazolin sodium within the kidney.
This research is essential because it demonstrates that whereas amoxicillin and gentamicin confirmed parallel results on the GR exercise in liver and kidney tissues each in vitro and in vivo, cefazolin sodium had a really robust impact on hepatic and renal GR in vivo. Moreover, the antibiotics used on this research induced oxidative stress in each tissues.
 Gentamicin sulfate |
|||
| GA7939-1G | Glentham Life Sciences | 1 g | EUR 46 |
Gentamicin sulfate |
|||
| GA7939-25G | Glentham Life Sciences | 25 g | EUR 158 |
Gentamicin sulfate |
|||
| GA7939-5G | Glentham Life Sciences | 5 g | EUR 78 |
 Gentamicin Sulfate USP |
|||
| G006-25G | TOKU-E | 25 g | EUR 392 |
Gentamicin Sulfate USP |
|||
| G006-5G | TOKU-E | 5 g | EUR 166 |
 Gentamicin Sulfate EP |
|||
| G007-25G | TOKU-E | 25 g | EUR 399 |
Gentamicin Sulfate EP |
|||
| G007-5G | TOKU-E | 5 g | EUR 183 |
 Gentamicin sulfate salt |
|||
| 20-abx082235 | Abbexa |
|
|
|
|||
 Gentamicin C1 Sulfate EvoPure® |
|||
| G031-10MG | TOKU-E | 10 mg | EUR 670 |
 Gentamicin C1a sulfate EvoPure® |
|||
| G032-10MG | TOKU-E | 10 mg | EUR 670 |
 Gentamicin C2 sulfate EvoPure® |
|||
| G033-10MG | TOKU-E | 10 mg | EUR 670 |
 Gentamicin C2a sulfate EvoPure® |
|||
| G034-10MG | TOKU-E | 10 mg | EUR 670 |
 Gentamicin A sulfate EvoPure® |
|||
| G035-10MG | TOKU-E | 10 mg | EUR 380 |
 Gentamicin X2 sulfate EvoPure® |
|||
| G036-2.5MG | TOKU-E | 2.5 mg | EUR 30 |
Gentamicin X2 sulfate EvoPure® |
|||
| G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 30 |
 Gentamicin C2b sulfate EvoPure® |
|||
| G062-10MG | TOKU-E | 10 mg | EUR 513 |
 0.1 G GENTAMICIN SULFATE, POWDER |
|||
| 61-098-RA | CORNING | 0,1 g/pk | EUR 62 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
 1 G GENTAMICIN SULFATE, POWDER |
|||
| 61-098-RF | CORNING | 1 g/pk | EUR 58 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
) Gentamicin Sulfate Solution (50 mg/mL in Water) |
|||
| G046-20ML | TOKU-E | 20 mL | EUR 110 |
 10 ML GENTAMICIN SULFATE, LIQUID 50 MG/ML SOLUTION |
|||
| 30-005-CR | CORNING | 10 mL/pk | EUR 433 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
) Gentamicin(GM) |
|||
| AG022 | Unibiotest | 1 mg | EUR 523 |
Gentamicin(GM) |
|||
| AT022 | Unibiotest | 1mg | EUR 945 |
 Gentamicin Antibody |
|||
| abx021011-200ug | Abbexa | 200 ug | EUR 328 |
|
|||
Gentamicin Antibody |
|||
| abx021012-1mg | Abbexa | 1 mg | EUR 954 |
|
|||
Gentamicin Antibody |
|||
| abx021013-1mg | Abbexa | 1 mg | EUR 481 |
|
|||
Gentamicin Antibody |
|||
| 20-abx210193 | Abbexa |
|
|
|
|||
 Gentamicin-BSA |
|||
| 80-1453 | Fitzgerald | 1 mg | EUR 651 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-1454 | Fitzgerald | 1 mg | EUR 651 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
 Gentamicin-OVA |
|||
| 80-1455 | Fitzgerald | 1 mg | EUR 651 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-OVA |
|||
| 80-1456 | Fitzgerald | 1 mg | EUR 651 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
Gentamicin-BSA |
|||
| 80-IG10 | Fitzgerald | 25 mg | EUR 381 |
|
Description: Conjugated Gentamicin-BSA hapten |
|||
 Gentamicin antibody |
|||
| 10-1541 | Fitzgerald | 100 ug | EUR 392 |
|
Description: Mouse monoclonal Gentamicin antibody |
|||
Gentamicin antibody |
|||
| 10-G02A | Fitzgerald | 500 ug | EUR 493 |
|
Description: Mouse monoclonal Gentamicin antibody |
|||
Gentamicin antibody |
|||
| 20C-CR1031S | Fitzgerald | 1 ml | EUR 219 |
|
Description: Sheep polyclonal Gentamicin antiserum |
|||
Gentamicin antibody |
|||
| 20-GG15 | Fitzgerald | 250 ul | EUR 184 |
|
Description: Goat polyclonal Gentamicin antibody |
|||
Gentamicin antibody |
|||
| 20-GR15 | Fitzgerald | 250 ul | EUR 208 |
|
Description: Rabbit polyclonal Gentamicin antibody |
|||
 Gentamicin-HRP |
|||
| 65-IG10 | Fitzgerald | 1 mg | EUR 597 |
|
Description: Conjugated Gentamicin-HRP hapten |
|||
 Gentamicin [KLH] |
|||
| DAG4484 | Creative Diagnostics | 1mg | EUR 1040 |
 Gentamicin [HRP] |
|||
| DAGA-032H | Creative Diagnostics | 1mg | EUR 1040 |
 Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
| CCM1123-010 | Bio Basic | 10 mL | EUR 64.05 |
|
|||
 Gentamicin, 50mg/ml |
|||
| CA003-001 | GenDepot | 10ml | EUR 91 |
 Antibody) Gentamicin (GTM) Antibody |
|||
| 20-abx175177 | Abbexa |
|
|
|
|||
 Gentamicin monoclonal antibody |
|||
| 10R-11497 | Fitzgerald | 1 mg | EUR 1110 |
|
Description: Mouse anti- Gentamicin monoclonal antibody |
|||
 Gentamicin ELISA kit |
|||
| 55R-2233 | Fitzgerald | 1 kit | EUR 698 |
|
Description: Gentamicin ELISA kit for use in research laboratory |
|||
 Gentamicin ELISA Kit |
|||
| K4206-100 | Biovision | EUR 990 | |
Gentamicin ELISA Kit |
|||
| DEIA047 | Creative Diagnostics | 96T | EUR 1032 |
|
Description: This kit can be used in quantitative and qualitative analysis of gentamicin residue in vaccine and cell culture. |
|||
 Gentamicin C1 pentaacetate salt |
|||
| GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 653 |
Gentamicin C1 pentaacetate salt |
|||
| GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 170 |
 Gentamicin C2 pentaacetate salt |
|||
| GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 349 |
 Gentamicin C1a pentaacetate salt |
|||
| GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 429 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 804 |
) Gentamicin ELISA Kit (OKAO00127) |
|||||||||||||
| OKAO00127 | Aviva Systems Biology | 96 Wells | EUR 532 | ||||||||||
|
Description: Description of target: Gentamicin is a complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity:
|
|||||||||||||
 ELISA Kit) Gentamicin (serum/urine) ELISA Kit |
|||
| K4315-100 | Biovision | EUR 756 | |
 Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54913MG | Creative Diagnostics | 1 mg | EUR 767 |
Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54914MG | Creative Diagnostics | 1 mg | EUR 767 |
 Sheep Anti Gentamicin Polyclonal Antibody |
|||
| DPBT-68266SG | Creative Diagnostics | 0.5 ml | EUR 767 |
) MEG (sulfate) |
|||
| C3992-10 | ApexBio | 10 mg | EUR 196 |
|
Description: MEG is a selective inhibitor of the inducible NO synthase (iNOS) [1]. NO synthase catalyses the oxidation of the amino acid L-arginine to citrulline and NO. |
|||
MEG (sulfate) |
|||
| C3992-100 | ApexBio | 100 mg | EUR 1121 |
|
Description: MEG is a selective inhibitor of the inducible NO synthase (iNOS) [1]. NO synthase catalyses the oxidation of the amino acid L-arginine to citrulline and NO. |
|||
MEG (sulfate) |
|||
| C3992-5 | ApexBio | 5 mg | EUR 126 |
|
Description: MEG is a selective inhibitor of the inducible NO synthase (iNOS) [1]. NO synthase catalyses the oxidation of the amino acid L-arginine to citrulline and NO. |
|||
MEG (sulfate) |
|||
| C3992-50 | ApexBio | 50 mg | EUR 661 |
|
Description: MEG is a selective inhibitor of the inducible NO synthase (iNOS) [1]. NO synthase catalyses the oxidation of the amino acid L-arginine to citrulline and NO. |
|||
) Nourseothricin (sulfate) |
|||
| C5155-10 | ApexBio | 10 mg | EUR 171 |
|
Description: Nourseothricin is a broad-spectrum antibiotic. Nourseothricin is a broad-spectrum antibiotic derived from Streptomyces noursei.In vitro: Nourseothricin, represents a mixture of streptothricins, mainly D and F. |
|||
Nourseothricin (sulfate) |
|||
| C5155-5 | ApexBio | 5 mg | EUR 119 |
|
Description: Nourseothricin is a broad-spectrum antibiotic. Nourseothricin is a broad-spectrum antibiotic derived from Streptomyces noursei.In vitro: Nourseothricin, represents a mixture of streptothricins, mainly D and F. |
|||
Nourseothricin (sulfate) |
|||
| C5155-50 | ApexBio | 50 mg | EUR 572 |
|
Description: Nourseothricin is a broad-spectrum antibiotic. Nourseothricin is a broad-spectrum antibiotic derived from Streptomyces noursei.In vitro: Nourseothricin, represents a mixture of streptothricins, mainly D and F. |
|||
 Apramycin Sulfate |
|||
| B1665-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Apramycin is an aminoglycoside antibiotic, which binds to the deep groove of the RNA. |
|||
 Capreomycin Sulfate |
|||
| B1689-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 108 |
|
Description: Capreomycin Sulfate is a cyclic peptide antibiotic and thought to inhibit protein synthesis by binding to the 70S ribosomal unit. |
|||
Capreomycin Sulfate |
|||
| B1689-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Capreomycin Sulfate is a cyclic peptide antibiotic and thought to inhibit protein synthesis by binding to the 70S ribosomal unit. |
|||
 Colistin Sulfate |
|||
| B1716-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Colistin is a cyclic cationic decapeptide linked to a fatty acid side chain, it belongs to a group of similarly structured bacterial antimicrobial peptides. |
|||
 Neomycin sulfate |
|||
| B1795-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 108 |
|
Description: Neomycin sulfate |
|||
Neomycin sulfate |
|||
| B1795-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Neomycin sulfate |
|||
 Netilmicin Sulfate |
|||
| B1796-5 | ApexBio | 5 mg | EUR 187 |
|
Description: Netilmicin Sulfate is a member of the aminoglycoside family of antibiotics. |
|||
 Paromomycin Sulfate |
|||
| B1808-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 113 |
|
Description: Paromomycin Sulfate is an aminoglycoside antibioticis inhibiting protein synthesis in non-resistant cells by binding to 16S ribosomal RNA. |
|||
Paromomycin Sulfate |
|||
| B1808-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Paromomycin Sulfate is an aminoglycoside antibioticis inhibiting protein synthesis in non-resistant cells by binding to 16S ribosomal RNA. |
|||
 Ribostamycin Sulfate |
|||
| B1825-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
|
Description: Ribostamycin is an aminoglycoside antibiotic, containing a neutral sugar moiety, and is produced by Streptomyces ribosidi?cus. |
|||
Ribostamycin Sulfate |
|||
| B1825-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Ribostamycin is an aminoglycoside antibiotic, containing a neutral sugar moiety, and is produced by Streptomyces ribosidi?cus. |
|||
 Cefoselis Sulfate |
|||
| B1906-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Cefoselis is a widely used beta-lactam antibiotic. |
|||
 Streptomycin sulfate |
|||
| B2034-5.1 | ApexBio | 10 mM (in 1mL H2O) | EUR 108 |
|
Description: Streptomycin sulfate |
|||
Streptomycin sulfate |
|||
| B2034-50 | ApexBio | 50 mg | EUR 128 |
|
Description: Streptomycin sulfate |
|||
Streptomycin sulfate |
|||
| B2034-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: Streptomycin sulfate |
|||
 Vincristine sulfate |
|||
| B2048-10 | Biovision | EUR 142 | |
Vincristine sulfate |
|||
| B2048-50 | Biovision | EUR 414 | |
 Hydroxychloroquine sulfate |
|||
| B2051-250 | Biovision | EUR 240 | |
Remedy of a chronically contaminated nasal silicone prosthesis with steady antibiotic irrigation and gentamicin-impregnated polymethylmethacrylate beads.
Contaminated nasal alloplasts in revision rhinoplasty is usually a advanced drawback, as timing between implant elimination and reconstruction is the most important limiting issue. Delaying reconstruction may end up in lack of mechanical assist, a constricted nostril, and in extreme circumstances, full nasal airway collapse and respiratory compromise.
On this case report, we describe a novel surgical strategy for the administration of a chronically contaminated nasal implant combining strategies used to deal with biomaterial-associated infections: antibiotic-impregnated polymethymethacrylate beads and a steady catheter-based antibiotic irrigation system.
We report a case of a persistent alloplastic-associated an infection following nasal reconstruction utilizing a silicone implant. We utilized a two-staged strategy. The concerned nasal implant was eliminated and changed briefly with gentamicin-impregnated polymethymethacrylate beads and a steady closed irrigation and drainage system with native and parenteral supply of antibiotics. Each modalities allowed for full eradication of the an infection.
As well as, the gentamicin beads supplied enough mechanical assist with a purpose to reduce the chance of pores and skin contracture. Twelve days after her preliminary surgical procedure, nasal reconstruction was carried out utilizing a cadaver bone graft. The affected person was adopted for two years postoperatively and has proven good outcomes with no proof of pores and skin contracture or recurrent an infection. This method might enable for shorter delay in revision surgical procedure and cut back the chance of long-term problems with out compromising useful and aesthetic outcomes
|
Gentamicin ELISA Kit |
|||
| K4206-100 | Biovision | EUR 990 | |
|
Gentamicin ELISA Kit |
|||
| DEIA047 | Creative Diagnostics | 96T | EUR 1032 |
|
Description: This kit can be used in quantitative and qualitative analysis of gentamicin residue in vaccine and cell culture. |
|||
|
Gentamicin ELISA Kit (OKAO00127) |
|||||||||||||
| OKAO00127 | Aviva Systems Biology | 96 Wells | EUR 532 | ||||||||||
|
Description: Description of target: Gentamicin is a complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.;Species reactivity: General;Application: ;Assay info: Assay Methodology: Competitive Inhibition ELISA;Sensitivity:
|
|||||||||||||
|
Gentamicin (serum/urine) ELISA Kit |
|||
| K4315-100 | Biovision | EUR 756 | |
|
Gentamicin(GM) |
|||
| AG022 | Unibiotest | 1 mg | EUR 523 |
|
Gentamicin sulfate |
|||
| B1270-1G | Biovision | EUR 142 | |
|
Gentamicin sulfate |
|||
| B1270-25G | Biovision | EUR 947 | |
|
Gentamicin sulfate |
|||
| B1270-5G | Biovision | EUR 338 | |
|
Gentamicin(GM) |
|||
| AT022 | Unibiotest | 1mg | EUR 945 |
) Gentamicin (sulfate) |
|||
| HY-A0276 | MedChemExpress | 500mg | EUR 119 |
|
Gentamicin sulfate |
|||
| GA7939-10G | Glentham Life Sciences | 10 g | EUR 102 |
|
Gentamicin sulfate |
|||
| GA7939-1G | Glentham Life Sciences | 1 g | EUR 46 |
|
Gentamicin sulfate |
|||
| GA7939-25G | Glentham Life Sciences | 25 g | EUR 158 |
|
Gentamicin sulfate |
|||
| GA7939-5G | Glentham Life Sciences | 5 g | EUR 78 |
|
Gentamicin Antibody |
|||
| abx021011-200ug | Abbexa | 200 ug | EUR 328 |
|
|||
|
Gentamicin Antibody |
|||
| abx021012-1mg | Abbexa | 1 mg | EUR 954 |
|
|||
|
Gentamicin Antibody |
|||
| abx021013-1mg | Abbexa | 1 mg | EUR 481 |
|
|||
|
Gentamicin Antibody |
|||
| 20-abx210193 | Abbexa |
|
|
|
|||
|
Gentamicin-BSA |
|||
| 80-1453 | Fitzgerald | 1 mg | EUR 651 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
|
Gentamicin-BSA |
|||
| 80-1454 | Fitzgerald | 1 mg | EUR 651 |
|
Description: BSA conjugated Gentamicin Hapten |
|||
|
Gentamicin-OVA |
|||
| 80-1455 | Fitzgerald | 1 mg | EUR 651 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
|
Gentamicin-OVA |
|||
| 80-1456 | Fitzgerald | 1 mg | EUR 651 |
|
Description: OVA conjugated Gentamicin Hapten |
|||
|
Gentamicin-BSA |
|||
| 80-IG10 | Fitzgerald | 25 mg | EUR 381 |
|
Description: Conjugated Gentamicin-BSA hapten |
|||
|
Gentamicin antibody |
|||
| 10-1541 | Fitzgerald | 100 ug | EUR 392 |
|
Description: Mouse monoclonal Gentamicin antibody |
|||
|
Gentamicin antibody |
|||
| 10-G02A | Fitzgerald | 500 ug | EUR 493 |
|
Description: Mouse monoclonal Gentamicin antibody |
|||
|
Gentamicin antibody |
|||
| 20C-CR1031S | Fitzgerald | 1 ml | EUR 219 |
|
Description: Sheep polyclonal Gentamicin antiserum |
|||
|
Gentamicin antibody |
|||
| 20-GG15 | Fitzgerald | 250 ul | EUR 184 |
|
Description: Goat polyclonal Gentamicin antibody |
|||
|
Gentamicin antibody |
|||
| 20-GR15 | Fitzgerald | 250 ul | EUR 208 |
|
Description: Rabbit polyclonal Gentamicin antibody |
|||
|
Gentamicin-HRP |
|||
| 65-IG10 | Fitzgerald | 1 mg | EUR 597 |
|
Description: Conjugated Gentamicin-HRP hapten |
|||
|
Gentamicin [KLH] |
|||
| DAG4484 | Creative Diagnostics | 1mg | EUR 1040 |
|
Gentamicin [HRP] |
|||
| DAGA-032H | Creative Diagnostics | 1mg | EUR 1040 |
|
Gentamicin Solution, Gentamicin Solution, 50 mg/mL |
|||
| CCM1123-010 | Bio Basic | 10 mL | EUR 64.05 |
|
|||
 Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed |
|||
| ELISA-1 | Alpha Diagnostics | 1 | EUR 202 |
|
Gentamicin, 50mg/ml |
|||
| CA003-001 | GenDepot | 10ml | EUR 91 |
|
Gentamicin Sulfate USP |
|||
| G006-25G | TOKU-E | 25 g | EUR 392 |
|
Gentamicin Sulfate USP |
|||
| G006-5G | TOKU-E | 5 g | EUR 166 |
|
Gentamicin Sulfate EP |
|||
| G007-25G | TOKU-E | 25 g | EUR 399 |
|
Gentamicin Sulfate EP |
|||
| G007-5G | TOKU-E | 5 g | EUR 183 |
|
Gentamicin sulfate salt |
|||
| 20-abx082235 | Abbexa |
|
|
|
|||
|
Gentamicin (GTM) Antibody |
|||
| 20-abx175177 | Abbexa |
|
|
|
|||
|
Gentamicin monoclonal antibody |
|||
| 10R-11497 | Fitzgerald | 1 mg | EUR 1110 |
|
Description: Mouse anti- Gentamicin monoclonal antibody |
|||
|
Gentamicin C1 pentaacetate salt |
|||
| GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 653 |
|
Gentamicin C1 pentaacetate salt |
|||
| GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 170 |
|
Gentamicin C2 pentaacetate salt |
|||
| GA2476-5MG | Glentham Life Sciences | 5 mg | EUR 349 |
|
Gentamicin C1a pentaacetate salt |
|||
| GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 429 |
|
Gentamicin C1a pentaacetate salt |
|||
| GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 804 |
 Frit Kit |
|||
| FRIT-KIT | Next Advance | 1each | EUR 124 |
|
Description: Kit to create frits in capillaries. Includes formamide, Kasil-1, Kasil-1624 and a cleaving tool. |
|||
 Column Packing Kit |
|||
| PACK-KIT | Next Advance | 1pack | EUR 1035 |
|
Description: Column packing kit for pressure cells. Includes: HPREG regulator, TBNG10 tubing, CAP-75 capillary, and STRB5X2 stir bar. |
|||
 PCR Mycoplasma Detection Kit |
|||
| M034-Kit | TOKU-E | Kit | EUR 266 |
|
Gentamicin C1 Sulfate EvoPure® |
|||
| G031-10MG | TOKU-E | 10 mg | EUR 670 |
|
Gentamicin C1a sulfate EvoPure® |
|||
| G032-10MG | TOKU-E | 10 mg | EUR 670 |
|
Gentamicin C2 sulfate EvoPure® |
|||
| G033-10MG | TOKU-E | 10 mg | EUR 670 |
|
Gentamicin C2a sulfate EvoPure® |
|||
| G034-10MG | TOKU-E | 10 mg | EUR 670 |
|
Gentamicin A sulfate EvoPure® |
|||
| G035-10MG | TOKU-E | 10 mg | EUR 380 |
|
Gentamicin X2 sulfate EvoPure® |
|||
| G036-2.5MG | TOKU-E | 2.5 mg | EUR 30 |
|
Gentamicin X2 sulfate EvoPure® |
|||
| G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 30 |
|
Gentamicin C2b sulfate EvoPure® |
|||
| G062-10MG | TOKU-E | 10 mg | EUR 513 |
|
0.1 G GENTAMICIN SULFATE, POWDER |
|||
| 61-098-RA | CORNING | 0,1 g/pk | EUR 62 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
|
1 G GENTAMICIN SULFATE, POWDER |
|||
| 61-098-RF | CORNING | 1 g/pk | EUR 58 |
|
Description: Media Catalog; Cell Culture Reagents |
|||
|
Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54913MG | Creative Diagnostics | 1 mg | EUR 767 |
|
Mouse Anti Gentamicin Monoclonal Antibody |
|||
| DMABT-54914MG | Creative Diagnostics | 1 mg | EUR 767 |
|
Sheep Anti Gentamicin Polyclonal Antibody |
|||
| DPBT-68266SG | Creative Diagnostics | 0.5 ml | EUR 767 |
 Cas9 Protein and T7 gRNA SmartNuclease Synthesis Kit |
|||
| CAS400A-KIT | SBI | 1 kit (10 rxn) | EUR 1110 |
|
|||
 CMV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV100PA-KIT | SBI | 1 Kit | EUR 1132 |
|
|||
 CMV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV105PA-KIT | SBI | 1 Kit | EUR 1132 |
|
|||
 MSCV-hspCas9-T2A-Puro SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV120PA-KIT | SBI | 1 Kit | EUR 1132 |
|
|||
 MSCV-hspCas9-EF1-GFP SmartNuclease Lentivector Plasmid + LentiStarter Packaging Kit |
|||
| CASLV125PA-KIT | SBI | 1 Kit | EUR 1132 |
|
|||
 Multiplex gRNA Kit + EF1-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS700A-KIT | SBI | 10 rxn | EUR 1132 |
|
|||
 Multiplex gRNA Kit + CAG-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS720A-KIT | SBI | 10 rxn | EUR 1132 |
|
|||
 Multiplex gRNA Kit + CMV-T7-hspCas9-H1-gRNA linearized SmartNuclease vector |
|||
| CAS740A-KIT | SBI | 10 rxn | EUR 1132 |
|
|||
) T7 gRNA SmartNuclease Synthesis Kit (includes CAS510A-1 & T7 IVT synthesis reagents) |
|||
| CAS510A-KIT | SBI | 1 Kit | EUR 805 |
|
|||
